Invention Grant
- Patent Title: Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule
-
Application No.: US16498557Application Date: 2018-03-30
-
Publication No.: US11644468B2Publication Date: 2023-05-09
- Inventor: Alexandre Prieur
- Applicant: Progastrine et Cancers S.à r.l.
- Applicant Address: LU Luxembourg
- Assignee: Progastrine et Cancers S.à r.L
- Current Assignee: Progastrine et Cancers S.à r.L
- Current Assignee Address: LU Luxembourg
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Agent Erin M. Dunston
- Priority: EP 305381 2017.03.30
- International Application: PCT/EP2018/058344 2018.03.30
- International Announcement: WO2018/178363A 2018.10.04
- Date entered country: 2019-09-27
- Main IPC: C07K16/26
- IPC: C07K16/26 ; A61P35/00 ; A61K39/395 ; A61K39/00 ; G01N33/574 ; C07K16/30 ; A61K45/06 ; C07K16/22 ; C07K16/28
Abstract:
The present invention relates to compositions and methods for the prevention or the treatment of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
Public/Granted literature
- US20210087265A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE Public/Granted day:2021-03-25
Information query
